Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tarsus Pharmaceuticals (TARS) Income from Continuing Operations (2020 - 2025)

Tarsus Pharmaceuticals has reported Income from Continuing Operations over the past 6 years, most recently at 6240000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 6240000.0 for Q4 2025, up 72.97% from a year ago — trailing twelve months through Dec 2025 was 64157000.0 (up 43.43% YoY), and the annual figure for FY2025 was 66418000.0, up 42.52%.
  • Income from Continuing Operations for Q4 2025 was 6240000.0 at Tarsus Pharmaceuticals, up from 12683000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for TARS hit a ceiling of 10410000.0 in Q1 2021 and a floor of 42461000.0 in Q4 2023.
  • Median Income from Continuing Operations over the past 5 years was 21334000.0 (2022), compared with a mean of 19365600.0.
  • Biggest five-year swings in Income from Continuing Operations: surged 631.94% in 2021 and later crashed 474.12% in 2023.
  • Tarsus Pharmaceuticals' Income from Continuing Operations stood at 14490000.0 in 2021, then grew by 5.96% to 13626000.0 in 2022, then crashed by 211.62% to 42461000.0 in 2023, then soared by 45.63% to 23086000.0 in 2024, then soared by 72.97% to 6240000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 6240000.0 (Q4 2025), 12683000.0 (Q3 2025), and 20195000.0 (Q2 2025) per Business Quant data.